TrialThe Journal of clinical investigation2012

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.

Fadila Benhamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.